TRAF7 meningiomas were enriched in MAPK (mitogen-activated protein kinases) signaling pathway members (Figure S3B, left panel), implying that TRAF7 mutants may induce expression of MAPK genes to drive meningioma growth. The gene discussed is WNK2; the disease is meningioma.